SCHEMBL17774944

SCHEMBL17774944

CN(CCO)c1ccc(N)c(C(N)=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ ALDH1A1 P00352 5/20 0.39
▸ TNIK Q9UKE5 1/20 0.35
▸ MAP4K4 O95819 1/20 0.35
▸ CHEK1 O14757 1/20 0.35
▸ APP P05067 1/20 0.34
▸ KDM4E B2RXH2 3/20 0.33
▸ MAPT P10636 3/20 0.33
▸ HPGD P15428 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CDC25B P30305 1/20 0.33
▸ CASP6 P55212 1/20 0.33
▸ RCE1 Q9Y256 1/20 0.33
▸ SLC9A5 Q14940 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ NOX1 Q9Y5S8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17774928 0.88 IKBKB (0.41) IKBKBALDH1A1CHEK1KDM4EMAPT
SCHEMBL17774956 0.88 IKBKB (0.41) IKBKBALDH1A1KDM4EMAPTHPGD
SCHEMBL17779281 0.85 MAPT (0.47) IKBKBALDH1A1KDM4EMAPTHPGD
SCHEMBL17774950 0.84 IKBKB (0.44) IKBKBALDH1A1KDM4EMAPTHPGD
SCHEMBL17774924 0.84 IKBKB (0.44) IKBKBL3MBTL1ALDH1A1KDM4EMAPT
SCHEMBL17774976 0.84 IKBKB (0.39) IKBKBALDH1A1KDM4EMAPTHPGD
SCHEMBL17774929 0.82 S100B (0.45) IKBKBL3MBTL1ALDH1A1KDM4EMAPT
SCHEMBL17774933 0.81 IKBKB (0.37) IKBKBALDH1A1CHEK1KDM4EMAPT
SCHEMBL5550257 0.81 L3MBTL1 (0.40) L3MBTL1ALDH1A1TNIKCHEK1APP
SCHEMBL17774973 0.81 IKBKB (0.39) IKBKBL3MBTL1ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9872822-B2 Process for dyeing in the presence of oxidation bases comprising at least one sulfonic, sulfonamide, sulfone, amid or acid group and a metal catalyst, device and ready-to-use composition L'OREAL (FR) 2018-01-23 — — US disclosed
US-9872822-B2 Process for dyeing in the presence of oxidation bases comprising at least one sulfonic, sulfonamide, sulfone, amid or acid group and a metal catalyst, device and ready-to-use composition L'OREAL (FR) 2018-01-23 — — US disclosed
US-20160143826-A1 PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION L'OREAL (FR) 2016-05-26 — — US disclosed
US-20160143826-A1 PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION L'OREAL (FR) 2016-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160143826-A1 PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION KRT18, ARSA, SQOR IKBKB 3089/4885L3MBTL1 4874/4885ALDH1A1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback